Previous Article | Next Article ![]()
Journal of Virology, November 1998, p. 8650-8658, Vol. 72, No. 11
Division of Hematology-Oncology,
Received 1 April 1998/Accepted 20 July 1998
The lack of clinical progression in some individuals despite
prolonged human immunodeficiency virus type 1 (HIV-1) infection may
result from infection with less-pathogenic viral strains. To address
this question, we examined the HIV-1 envelope protein from a donor with
a low viral burden, stable CD4+ T-lymphocyte counts, and
little evidence of CD8+ T-cell expansion, activation, or
immune activity. To avoid potential changes in
envelope function resulting from selection in vitro, envelope
clones were constructed by using viral RNA isolated from uncultured
peripheral blood mononuclear cells (PBMC). The data showed that
recombinant viruses containing envelope sequences derived from
RNA isolated from patient PBMC replicated poorly in primary
CD4+ T cells but demonstrated efficient growth in
macrophages. The unusual phenotype of these viruses could not be
explained solely by differential utilization of coreceptors since the
chimeric viruses, as well as an uncloned isolate obtained from the same visit date, can utilize CCR5. In addition, the donor's own cells appeared resistant to infection with chimeric viruses
containing autologous envelope sequences. Genotype analysis revealed
that the donor was heterozygous for the previously described 32-bp deletion in CCR5 which may be linked with prolonged survival in HIV-1-infected individuals. These data suggest that the changes in
envelope sequences confer properties of viral attenuation, which
together with the CCR5 +/
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Potential Contributions of Viral Envelope and Host Genetic
Factors in a Human Immunodeficiency Virus Type 1-Infected
Long-Term Survivor
32 genotype could account for the long-term
survival of this patient.
*
Corresponding author. Mailing address: 11-934 Factor,
Department of Medicine, UCLA School of Medicine and the UCLA AIDS
Institute, Los Angeles, CA 90095-1678. Phone: (310) 825-4793; Fax:
(310) 794-7682. E-mail: rtaweesu{at}ucla.edu.
Present address: University of Texas Medical Branch, Galveston, TX
77555.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»